Why the study?
Despite the proven benefits of Guideline-Directed Medical Therapy in chronic heart failure, its implementation varies across regions due to non-adherence, provider gaps, and systemic challenges.
Answers are grounded in this paper and cite their sources.
This review emphasizes the need for collaborative efforts to improve the implementation of guideline-directed medical therapy for chronic heart failure, particularly in resource-constrained settings.
Chronic heart failure (CHF) is a progressive condition with high morbidity and mortality rates worldwide. Guideline-Directed Medical Therapy (GDMT) offers evidence-based guidelines for treating CHF, including pharmacological therapies that have been shown to improve patient outcomes. Despite its benefits, GDMT implementation varies across regions due to factors such as patient non-adherence, healthcare provider gaps, and systemic challenges. This literature review summarizes the current understanding of GDMT, focusing on its components, clinical efficacy, implementation challenges, and strategies to enhance adherence. This literature was conducted using databases such as Google Scholar, PubMed, and ScienceDirect using keywords relevant to chronic heart failure and guideline-directed medical therapy. The review highlights the importance of collaborative efforts to bridge the gap between guideline recommendations and practices, especially in resource-constrained settings, in order to maximize care for CHF patients.
No takes yet. Share an insight, caveat, or question.
Subagyo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: